News
NBY
0.5850
0.00%
0.0000
NovaBay Pharmaceuticals Delays Yearly Report Filing
TipRanks · 6h ago
Weekly Report: what happened at NBY last week (0324-0328)?
Weekly Report · 1d ago
Weekly Report: what happened at NBY last week (0317-0321)?
Weekly Report · 03/24 12:09
Weekly Report: what happened at NBY last week (0310-0314)?
Weekly Report · 03/17 12:24
Weekly Report: what happened at NBY last week (0303-0307)?
Weekly Report · 03/10 12:26
NovaBay Plans To Hold Virtual Special Meeting On April 16, 2025, At Which Stockholders Will Vote On Proposal For Liquidation And Dissolution
Benzinga · 03/07 11:51
NovaBay Pharmaceuticals to Hold Special Meeting of Stockholders
Barchart · 03/07 05:50
Weekly Report: what happened at NBY last week (0224-0228)?
Weekly Report · 03/03 12:24
Weekly Report: what happened at NBY last week (0217-0221)?
Weekly Report · 02/24 12:25
Weekly Report: what happened at NBY last week (0210-0214)?
Weekly Report · 02/17 12:21
Weekly Report: what happened at NBY last week (0203-0207)?
Weekly Report · 02/10 12:12
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Benzinga · 02/05 12:05
Weekly Report: what happened at NBY last week (0127-0131)?
Weekly Report · 02/03 12:19
Catalyst Watch: Tariff drama, OPEC+, Alphabet and Amazon earnings, Lennar spinoff
Seeking Alpha · 01/31 20:00
Weekly Report: what happened at NBY last week (0120-0124)?
Weekly Report · 01/27 12:23
NovaBay Pharma’s Strategic Shift and Liquidation Plans
TipRanks · 01/23 13:31
Weekly Report: what happened at NBY last week (0113-0117)?
Weekly Report · 01/20 12:10
Weekly Report: what happened at NBY last week (0106-0110)?
Weekly Report · 01/13 12:12
12 Health Care Stocks Moving In Monday's Pre-Market Session
Benzinga · 01/13 12:05
Weekly Report: what happened at NBY last week (1230-0103)?
Weekly Report · 01/06 12:23
More
Webull provides a variety of real-time NBY stock news. You can receive the latest news about Novabay Pharma through multiple platforms. This information may help you make smarter investment decisions.
About NBY
NovaBay Pharmaceuticals, Inc. is engaged in wound care products. The Company manufactures and sells its proprietary form of hypochlorous acid for the wound care market through its NeutroPhase and PhaseOne branded products. NeutroPhase and PhaseOne are used for cleansing and irrigation as part of surgical procedures, as well as treating wounds, burns, ulcers and other injuries.